Advertisement
The U.S. Food and Drug Administration on Tuesday approved the sale of two reduced-nicotine cigarettes.

FDA Approves Sale of Low-Nicotine Cigarettes

0
Nicotine content of the two newly approved cigarettes is less than 1 mg per cigarette
Inpatient palliative care teams are reaching a broader mix of patients earlier in the course of their illness

Palliative Care Reaching More Inpatients With Serious Illness

0
From 2013 to 2017, more patients discharged alive, consistent with palliative care earlier in illness
Death within five years of first unplanned hospital admission is common among older adults

Five-Year Mortality Up in Older Adults With Unplanned Admission

0
Among seniors, just over half of all deaths occurred in those with first unplanned hospital admission
A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT interval

Many Lung Cancer Patients Receive Meds That Prolong QTc Interval

0
Receipt of these medications prolonging corrected QT interval limits patients' eligibility for clinical trials
Rural Medicare beneficiaries with complex chronic conditions have higher preventable hospitalization and mortality rates than their urban peers

Outcomes Worse for Rural Residents With Chronic Conditions

0
Higher preventable hospitalization and mortality rates partly due to reduced access to specialists
Current use of electronic cigarettes is an independent risk factor for respiratory disease

E-Cigarette Use Independent Risk Factor for Chronic Lung Disease

0
Odds of developing respiratory disease higher for dual users of e-cigarettes, combustible tobacco
Stephen Hahn

Hahn Confirmed as New FDA Chief

0
One major challenge facing Hahn is the teen vaping epidemic
The incidence and prevalence of nontuberculous mycobacterial lung disease is increasing in the United States

Incidence of Nontuberculous Mycobacteria Lung Disease Rising

0
Incidence and prevalence of NTM lung disease increasing across U.S., especially for women, older adults
Not all patients have access to new

Access to High-Cost Targeted Treatments Varies for Lung Cancer

0
Patients treated at a National Cancer Institute-designated center more likely to receive these drugs for lung cancer

Radiological Society of North America, Dec. 1-6

0
The 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America The annual meeting of the Radiological Society of North...